These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 26868367)
1. Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders. Rosell AM; Pena LD; Schoch K; Spillmann R; Sullivan J; Hooper SR; Jiang YH; Mathey-Andrews N; Goldstein DB; Shashi V J Genet Couns; 2016 Oct; 25(5):1019-31. PubMed ID: 26868367 [TBL] [Abstract][Full Text] [Related]
2. Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context. van Slobbe M; van Haeringen A; Vissers LELM; Bijlsma EK; Rutten JW; Suerink M; Nibbeling EAR; Ruivenkamp CAL; Koene S Eur J Pediatr; 2024 Jan; 183(1):345-355. PubMed ID: 37889289 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions. Tan TY; Dillon OJ; Stark Z; Schofield D; Alam K; Shrestha R; Chong B; Phelan D; Brett GR; Creed E; Jarmolowicz A; Yap P; Walsh M; Downie L; Amor DJ; Savarirayan R; McGillivray G; Yeung A; Peters H; Robertson SJ; Robinson AJ; Macciocca I; Sadedin S; Bell K; Oshlack A; Georgeson P; Thorne N; Gaff C; White SM JAMA Pediatr; 2017 Sep; 171(9):855-862. PubMed ID: 28759686 [TBL] [Abstract][Full Text] [Related]
8. Parents' perceptions of personal utility of exome sequencing results. Mollison L; O'Daniel JM; Henderson GE; Berg JS; Skinner D Genet Med; 2020 Apr; 22(4):752-757. PubMed ID: 31857707 [TBL] [Abstract][Full Text] [Related]
9. Parental motivations for and adaptation to trio-exome sequencing in a prospective prenatal testing cohort: Beyond the diagnosis. Talati AN; Gilmore KL; Hardisty EE; Lyerly AD; Rini C; Vora NL Prenat Diagn; 2022 May; 42(6):775-782. PubMed ID: 35132674 [TBL] [Abstract][Full Text] [Related]
10. Promises, pitfalls and practicalities of prenatal whole exome sequencing. Best S; Wou K; Vora N; Van der Veyver IB; Wapner R; Chitty LS Prenat Diagn; 2018 Jan; 38(1):10-19. PubMed ID: 28654730 [TBL] [Abstract][Full Text] [Related]
11. Molecular diagnostic experience of whole-exome sequencing in adult patients. Posey JE; Rosenfeld JA; James RA; Bainbridge M; Niu Z; Wang X; Dhar S; Wiszniewski W; Akdemir ZH; Gambin T; Xia F; Person RE; Walkiewicz M; Shaw CA; Sutton VR; Beaudet AL; Muzny D; Eng CM; Yang Y; Gibbs RA; Lupski JR; Boerwinkle E; Plon SE Genet Med; 2016 Jul; 18(7):678-85. PubMed ID: 26633545 [TBL] [Abstract][Full Text] [Related]
12. Much ado about nothing: A qualitative study of the experiences of an average-risk population receiving results of exome sequencing. Rego S; Dagan-Rosenfeld O; Bivona SA; Snyder MP; Ormond KE J Genet Couns; 2019 Apr; 28(2):428-437. PubMed ID: 30835913 [TBL] [Abstract][Full Text] [Related]
13. Bayesian cost-effectiveness analysis of Whole genome sequencing versus Whole exome sequencing in a pediatric population with suspected genetic disorders. Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Damiani G Eur J Health Econ; 2024 Aug; 25(6):999-1011. PubMed ID: 37975990 [TBL] [Abstract][Full Text] [Related]
14. Developmental and epileptic encephalopathy: Personal utility of a genetic diagnosis for families. Jeffrey JS; Leathem J; King C; Mefford HC; Ross K; Sadleir LG Epilepsia Open; 2021 Mar; 6(1):149-159. PubMed ID: 33681658 [TBL] [Abstract][Full Text] [Related]
15. Family genetic result communication in rare and undiagnosed disease communities: Understanding the practice. Studwell CM; Glanton E; ; Sinsheimer JS; Palmer CGS; LeBlanc K J Genet Couns; 2021 Apr; 30(2):439-447. PubMed ID: 33108040 [TBL] [Abstract][Full Text] [Related]
16. Parental preferences toward genomic sequencing for non-medically actionable conditions in children: a discrete-choice experiment. Lewis MA; Stine A; Paquin RS; Mansfield C; Wood D; Rini C; Roche MI; Powell CM; Berg JS; Bailey DB Genet Med; 2018 Feb; 20(2):181-189. PubMed ID: 28771249 [TBL] [Abstract][Full Text] [Related]
17. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis. Pucel J; Briere LC; Reuter C; Gochyyev P; ; LeBlanc K Genet Med; 2024 Jun; 26(6):101115. PubMed ID: 38436216 [TBL] [Abstract][Full Text] [Related]
18. The book is just being written: The enduring journey of parents of children with emerging- ultrarare disorders. Stafford-Smith B; Sullivan JA; McAlister M; Walley N; Shashi V; McConkie-Rosell A J Genet Couns; 2024 Apr; ():. PubMed ID: 38562053 [TBL] [Abstract][Full Text] [Related]
19. Comparison of first-tier whole-exome sequencing with a multi-step traditional approach for diagnosing paediatric outpatients: An Italian prospective study. Rosina E; Pezzani L; Apuril E; Pezzoli L; Marchetti D; Bellini M; Lucca C; Meossi C; Massimello M; Mariani M; Scatigno A; Cattaneo E; Colombo L; Maitz S; Cereda A; Milani D; Spaccini L; Bedeschi MF; Selicorni A; Iascone M Mol Genet Genomic Med; 2024 Jan; 12(1):e2316. PubMed ID: 38041506 [TBL] [Abstract][Full Text] [Related]